Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11660325
Compositions and methods of targeting cancer stem cells
granted -
US 11660318
Use of adipose tissue-derived stromal stem cells in treating fistula
granted -
US 11642401
Activation of resident memory T cells for cancer immunotherapy
granted -
US 11629334
Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
granted -
US 11631483
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 11622977
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11613754
Toxic RNAi active seed sequences for killing cancer cells
granted -
US 11613735
Methods for reprograming non-hepatocyte cells into hepatocyte cells
granted -
US 11613739
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells
granted -
US 11591622
Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder
granted -
US 11591381
Gene-edited natural killer cells
granted -
US 11583556
Modified cells and methods of therapy
granted -
US 11583557
Placenta-derived multipotent stem cells
granted -
US 11578309
Universal donor cells
granted -
US 11571445
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11572541
Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer
granted -
US 11566230
Universal donor cells
granted -
US 11566228
Hemangio-colony forming cells
granted -
US 11566242
Methods and compositions for reprogramming cells
granted -
US 11559551
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11555057
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
granted -
US 11504402
Compositions comprising bacterially derived minicells and methods of using the same
granted -
US 11497773
Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
granted -
US 11485976
Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same
granted